Patent Assignment
Reel/Frame 070240/0338
Assignment of Assignor's Interest
Recorded: 2025-02-17
Pages: 3
Assignor
NESTOR, JOHN J.
Executed: 2018-01-26
Assignee
SPITFIRE PHARMA, INC.
400 OYSTER POINT BLVD., SUITE 202, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(2)
Peptide Pharmaceuticals for Treatment of Nash and Other Disorders
Peptide Pharmaceuticals for Treatment of Nash and Other Disorders
Application:
19/030,991 →
Publication:
US 2025/0281450
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 19, 2023
From: SPITFIRE PHARMA LLC
To: MEDERIS DIABETES, LLC
Reel/Frame 063985/0868 →
Assignment of Assignor's Interest
Feb 17, 2025
From: SPIRFIRE PHARMA, INC.
To: MEDERIS DIABETES LLC
Reel/Frame 070232/0516 →
Affidavit of Address Change
Feb 17, 2025
From: MEDERIS DIABETES, LLC
To: MEDERIS DIABETES LLC
Reel/Frame 070240/0403 →
Security Interest
May 14, 2025
From: ALTIMMUNE, INC.; SPITFIRE PHARMA, LLC
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 071108/0692 →